Levetiracetam LEV CAS 102767-28-2 API Hoobkas USP EP Standard High Purity

Lus piav qhia luv luv:

Lub npe tshuaj: Levetiracetam;LEV

CAS: 102767-28-2 Nr

Cov tsos mob: Dawb los yog yuav luag dawb crystals hmoov

Kev Ntsuas: 98.0% ~ 102.0%

Thib peb-tiam Antiepileptic Tshuaj

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim tshuaj paus Supply nrog High Purity thiab ruaj khov zoo
Lub npe tshuaj: Levetiracetam
CAS: 102767-28-2 Nr
API USP / EP Standard, Kev Lag Luam Ntau Lawm
Thib peb-tiam Antiepileptic Tshuaj

Chemical Properties:

Tshuaj npe	Levetiracetam
Synonyms	LEV;(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;UB-L059
CAS Nr	102767-28-2
CAT Number	Tus Qauv Zauv: RF-API61
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C8H14N2O2
Molecular Luj	170.21 Nws
Melting Point	116.0-119.0 ℃
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Dawb los yog Yuav luag Dawb Crystals Hmoov
Identification IR	Spectrum tau txais los ntawm cov qauv muaj nrog uas tau los ntawm cov khoom siv siv
Qhov tshwm sim ntawm kev daws teeb meem	Ntshiab thiab tsis muaj xim ntau dua li BY6
Enantiomeric Purity Impurity D	≤ 0.80%
Dej	≤0.50%
Sulfated tshauv	≤0.10%
Hnyav Hlau	≤ 0.001%
Yam khoom muaj feem
impurity A	≤ 0.30%
Tej yam tsis meej tsis meej	≤ 0.05%
Tag nrho Unspecified Impurities	≤0.10%
Tag nrho cov impurities	≤ 0.40%
impurity F	≤0.10%
Residual Solvents
Benzene	≤ 2 ppm
Dichloromethane	≤600ppm
Ethyl Acetate	≤5000ppm
Acetone	≤5000ppm
Assay	98.0% ~ 102.0%.
Test Standard	USP Txuj;EP Txheem
Kev siv	API Thib Peb-tiam Antiepileptic Tshuaj

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.

Qhov zoo:

FAQ:

Daim ntawv thov:

Levetiracetam (CAS: 102767-28-2), ib tug derivative ntawm pilacetam, yog ib tug tshiab tiam thib peb-tiam tshuaj antiepileptic pom zoo los ntawm US FDA nyob rau hauv 1999. Nws yog thawj zaug siv rau kev kho mob ntawm ib nrab qaug dab peg nyob rau hauv cov neeg laus.Hauv xyoo 2005, Levetiracetam tau pom zoo hauv cov ntsiav tshuaj ntawm qhov ncauj thiab cov kev daws teeb meem rau kev kho mob ntawm ib nrab qaug dab peg hauv cov menyuam yaus hnub nyoog 4 xyoos thiab laus dua.Nws yog tsuas yog siv rau kev kho mob ntxiv ntawm kev qaug dab peg ib nrab ntawm cov neeg laus thiab cov menyuam yaus hnub nyoog qis dua 4 xyoos, thiab tseem tuaj yeem siv rau qee qhov qaug dab peg thiab qaug dab peg hauv cov neeg laus.Nws kuj muaj qee yam kev kho mob ntawm myoclonic qaug dab peg nyob rau hauv cov hluas, refractory epilepsy, tsis tuaj kawm ntawv nyob rau hauv cov me nyuam thiab mob qaug dab peg.